KIMBERLY GRADY: Open Payments
NPI 1588340210 · FORT MYERS, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$4,037 in 151 payments from 26 companies in 2025. Trend: 2023 $671 · 2024 $3,022 · 2025 $4,037
Food & beverage: $3,940Education: $97
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. | 33 | $952 |
| AstraZeneca Pharmaceuticals LP | 30 | $854 |
| Insmed, Inc. | 19 | $410 |
| Regeneron Healthcare Solutions, Inc. | 22 | $358 |
| GENZYME CORPORATION | 4 | $226 |
| JAZZ PHARMACEUTICALS INC. | 5 | $212 |
| Phathom Pharmaceuticals, Inc. | 1 | $122 |
| Lilly USA, LLC | 1 | $119 |
| Viatris Specialty LLC | 4 | $81 |
| United Therapeutics Corporation | 2 | $62 |
Products named: DUPIXENT, AREXVY, Arikayce, NUCALA, TRELEGY ELLIPTA, AIRSUPRA, FASENRA, XYWAV.
Industry payments across FL — which companies pay providers there.
